Donepezil 23 mg Tablets and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Donepezil 23 mg Tablets and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: donepezil
Brand name: Aricept, Aricept ODT
Synonyms: Donepezil
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Donepezil 23 mg Tablets-Insulin degludec
- Donepezil 23 mg Tablets-Insulin Degludec (U-100) Prefilled Pens
- Donepezil 23 mg Tablets-Insulin Degludec (U-100) Vials
- Donepezil 23 mg Tablets-Insulin Degludec (U-200) Prefilled Pens
- Donepezil 23 mg Tablets-Insulin degludec and liraglutide
- Donepezil 23 mg Tablets-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Donepezil and memantine
- Insulin aspart, recombinant Subcutaneous-Donepezil ER Tablets
- Insulin aspart, recombinant Subcutaneous-Donepezil Hydrochloride
- Insulin aspart, recombinant Subcutaneous-Donepezil Orally Disintegrating Tablet
- Insulin aspart, recombinant Subcutaneous-Donepezil Orally Disintegrating Tablets
- Insulin aspart, recombinant Subcutaneous-Donepezil Tablets